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1. Introduction 
Multiple sclerosis (MS) is one of the most difficult to diagnose neurological diseases because 
its clinical manifestations are highly variable and the disease course also shows 
unpredictable individual patterns. We are far from understanding the complexities that 
underlie this variability, but certain patterns clearly emerge. First, it has become clear that 
different genetic backgrounds will lead to different manifestations of an autoimmune T cell 
attack on the central nervous system (CNS) (Hoppenbrouwers and Hintzen, 2010). It is also 
clear that differences in the CNS antigen-specificity of the T cell response can result in a 
differential involvement of anatomical regions of the CNS (Berger et al., 1997; Kuerten et al., 
2007). Differences in lesion localization are a typical feature of MS, termed dissemination in 
space, and are likely to cause heterogeneity in clinical symptoms. There is evidence for the 
prevalence of either T cell-/macrophage- or antibody-/complement-mediated CNS 
demyelination versus a primary oligodendrogliopathy in MS patients (Lucchinetti et al., 
2000). While the patterns of demyelination remain the same in individual patients over time, 
heterogeneity is evident when comparing different patients (Lucchinetti et al., 2000). In 
addition to these rather defined parameters of CNS histopathology (termed “pattern I-IV” 
by Lucchinetti et al., 2000) there are dynamic elements of the inflammatory cascade that can 
result in interindividual variations of disease progression. Among these are the extent of 
antigen determinant spreading (Lehmann et al., 1992; McRae et al., 1995), the prevalence of 
antigens in different CNS regions to which the spreading occurs (Targoni et al., 2001) as well 
as the rate at which regulatory or compensatory reactions of the immune system surface to 
counterregulate the damage of the target organ (Kasper et al., 2007).  
Due to the impossibility of obtaining CNS tissue samples from individual patients 
repeatedly over time, studies as to the pathogenesis of the human disease need to rely on 
suitable animal models. To study pathologic features of MS three main animal models are 
used: disease induction by toxic agents, viral models, and finally different types of 
experimental autoimmune encephalomyelitis (EAE). Toxic agents like the copper chelator 
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cuprizone cause demyelination in the relative absence of inflammation or axonal damage. 
Lesions induced in the cuprizone model typically resemble primary oligodendrocyte 
dystrophy in MS patients, while lacking the characteristic T cell infiltrate. The cuprizone 
model has no autoimmune component. Still, it is well-suited to investigate principle features 
of de- and remyelination in the CNS (Kipp et al., 2009). Intracerebral inoculation of Theiler’s 
murine encephalomyelitis virus (TMEV) is used to investigate how viral infections can 
induce CNS autoimmunity. After an early, subtle disease period, susceptible mouse strains 
develop brain and spinal cord inflammation, demyelination and axonal damage. The clinical 
course resembles that of chronic, progressive MS (Tsunoda et al., 2010). However, EAE 
remains the most intensively studied animal model of MS.  
2. Experimental Autoimmune Encephalitis (EAE)  
EAE was introduced by Thomas Rivers and his colleagues in the early 1930s (van Epps, 
2005). Since then, it has been subject to elaborate studies (reviewed in Goverman and Brabb, 
1996; Steinman, 1999; Hemmer et al., 2002). Animals studied initially included guinea pigs 
and rats, in particular the Lewis rat, but later also involved marmoset monkeys and mice – 
the latter being the dominant model organisms used nowadays (Gold et al., 2006). EAE can 
either be induced by active immunization with CNS antigens in adjuvant (active EAE) or by 
the passive transfer of encephalitogenic T cells (adoptive/passive EAE). In addition, 
spontaneous EAE models relying on transgenic animals exist (Fig. 1). 
 
Fig. 1. The interplay between genetic background, disease triggering antigen and the mode 
of disease induction results in differences in EAE outcome.    
Originally, whole spinal cord homogenate (SCH) (Einstein et al., 1962; Bernard & Carnegie, 
1975; van Epps, 2005) was used for disease induction, before specific target antigens were 
defined. Early efforts to characterize the encephalitogenic antigen in SCH identified myelin 
basic protein (MBP) (Einstein et al. 1962; Martenson et al., 1970; Hashim et al., 1975) 
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comprising approximately 30 – 40% of the proteins in the myelin sheath. H-2u mice, in 
particular the B10.PL and PL/J strains are highly susceptible to MBP- or MBP peptide-
induced EAE (Fritz et al., 1983 and 1985), while most common mouse strains, including 
C57BL/6 (B6) mice are resistant to MBP-induced disease (Bernard, 1976; Fritz and Zhao, 
1996; Gasser et al., 1990; Skundric et al., 1994). The in-depth characterization of the B10.PL 
and PL/J model revealed highly restricted T cell responses to MBP involving a single 
immune dominant determinant and a limited usage of T cell receptor (TCR) chains (Zamvil 
et al., 1988; Urban et al., 1988; Kumar and Sercarz, 1994; Radu et al., 2000). Since similar 
findings were made in the Lewis rat (Burns et al., 1989), hopes emerged that such features 
could also apply to MS, providing therapeutic possibilities. These perspectives faded as 
diverse T cell repertoires were found in the proteolipid protein (PLP):139-151-induced EAE 
of SJL mice (Kuchroo et al., 1992) and after realizing that autoimmune T cell repertoires 
undergo determinant spreading (Lehmann et al., 1992; McRae et al., 1995; Jansson et al., 
1995; Yu et al., 1996; Tuohy et al., 1999). Recent studies of antigen-specific autoantibodies in 
EAE have also provided for the diversification of the autoimmune response (Stefferl et al., 
2000; Cross et al., 2001). PLP constitutes approximately 50% of the myelin proteins. As with 
MBP-induced EAE, only few strains were found to be susceptible to PLP-induced EAE. 
C57BL/6 mice were reported to be resistant (Tuohy, 1993; Mendel et al., 1995; Fritz and 
Zhao, 1996; Klein et al., 2000). The search for additional encephalitogenic antigens identified 
myelin oligodendrocyte glycoprotein (MOG) (Lebar et al., 1986; Mendel et al., 1995 and 
1996; Schmidt, 1999), myelin associated glycoprotein (MAG) (Schmidt, 1999; Morris-Downes 
et al., 2002; Weerth et al., 1999), myelin oligodendrocyte basic protein (MOBP)  (Schmidt, 
1999; Holz et al., 2000; de Rosbo et al., 2004), oligodendrocyte-specific glycoprotein (OSP) 
(Morris-Downes, 2002), 2’,3’-cyclic nucleotide 3’ phosphodiesterase (CNPase) (Schmidt, 
1999; Morris-Downes et al., 2002),-synuclein (Mor et al., 2003) as well as S100 which is 
not only expressed on astrocytes, but also in many other tissues including the eye, thymus, 
spleen and lymph nodes (Kojima et al., 1997; Schmidt, 1999). 
Each combination of antigen with the respective susceptible strain and also considering the 
mode/protocol of disease induction results in a characteristic form of EAE (Goverman & 
Brabb, 1996; Steinman, 1999; Schmidt, 1999) (Fig. 1). The different EAE models show 
fundamental differences, however. For example, the MBP-induced disease in B10.PL and 
PL/J mice is monophasic: the mice completely recover after a single episode of short acute 
disease and become resistant to re-induction of EAE (Waxman et al., 1980). PLP peptide 139-
151-induced EAE in SJL mice is remitting-relapsing (Hofstetter et al., 2002), while the 
disease elicited by MOG:35-55 in C57BL/6 mice is chronic (Eugster et al., 1999). In addition, 
the different EAE models involve differences in CNS histopathology and the role of antigen-
specific antibodies, which will be described in detail below.  
There have been extensive discussions regarding which antigen/strain combination 
provides the “best” EAE model for MS. The prevalent view is that none of them 
individually, but all of them jointly are best (Schmidt, 1999; van Epps, 2005; Hafler et al., 
2005). MS does not seem to be a single disease entity, but rather involves a profound 
heterogeneity. As Vijay Kuchroo (Harvard University) once pointed out “each EAE model 
recapitulates a small piece of the human disease”, thus facilitating the analysis of each single 
step disrupting immune competence leading finally to a severe autoimmune disease (van 
Epps, 2005; Steinman and Zamvil, 2006). EAE is an appropriate model for studies of basic 
mechanisms that underlie autoimmune pathology because, unlike in spontaneous 
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autoimmune diseases, the autoantigen, the time point and the site of the ensuing 
autoimmune response is known, and the type of cytokine differentiation of the induced T 
cells can be directed (Forsthuber et al., 1996; Yip et al., 1999). Being able to control the above 
parameters as well as the ability to monitor the autoantigen-specific T cells in the course of 
the disease renders EAE suitable for studies aiming at defining the mechanisms of 
therapeutic interventions. Genetically-manipulated mice have been and will continue to 
gain increasing importance for such studies.  
Traditionally, mechanistic studies have relied on the use of antibodies and on complex 
manipulations of mice. However, such treatments that can be applied to essentially any EAE 
model, do not necessarily permit unambiguous conclusions. For example, when a cell 
surface marker-specific antibody is injected to study the role of that molecule in EAE, the 
antibody might have a clinical effect on the disease, but it could be due to a multitude of 
mechanisms. The antibody could deplete the marker positive cells via the activation of 
complement, antibody-dependent cell-mediated cytotoxicity (ADCC) or apoptosis 
(Cebecauer et al., 2005), which in turn may be associated with a varying degree of 
inflammation causing unaccounted effects. Alternatively (or in addition) antibodies can 
inactivate or activate the marker positive cells, with variable bystander cell involvement. 
When antibodies are injected to study the role of a cytokine, the clinical effect seen can result 
from the neutralization of the cytokine, or on the contrary, from the prolongation of the half-
life of that cytokine. For such reasons, the use of antibodies for mechanistic studies has 
frequently resulted in contradictory, inconclusive data (Dittmer and Hasenkrug, 1999; 
Silvera et al., 2001). The use of genetically-targeted mice, along with adoptive transfers of 
cells that express/do not express molecules of interest is increasingly becoming 
indispensable for mechanism-oriented studies, and the more this “tool box” expands the 
more powerful it will become. Most gene knock-out/knock-in mice have been generated on 
the 129 (H-2b) background and backcrossed to H-2 congenic C57BL/6 mice. Instead of 
having to move each new member of this ever expanding “toolbox” to the background of 
each EAE susceptible strain, it is much more effective to be able to study EAE in C57BL/6 
mice. This is why MOG:35-55-induced EAE in C57BL/6 mice is increasingly becoming 
essential for mechanism-oriented studies – and why at the same time it is problematic to 
rely on this single EAE model for MS. To this end, we set out to establish and characterize 
additional EAE models for C57BL/6 mice. PLP protein-induced EAE has not been 
extensively studied; unlike the hydrophilic MBP molecule, PLP is highly hydrophobic and 
thus as a protein very difficult to utilize (Tuohy, 1993). PLP as an antigen for EAE induction 
established itself only after the encephalitogenic PLP peptide 139-151 had been identified for 
SJL mice (Kuchroo et al., 1992; Lehmann et al., 1992). Only recently, PLP peptide 178-191-
elicited disease in C57BL/6 mice has been introduced (Tompkins et al., 2002), but this model 
still awaits thorough characterization. Encompassing most potential determinants of the two 
major myelin antigens, MBP and PLP, the MP4 fusion protein was generated as a drug 
candidate for MS (Elliott et al., 1996). MP4 contains the three hydrophilic loops of PLP 
(domains I, II and III; Fig. 2A), while the four hydrophobic transmembrane sequences have 
been excised. These hydrophilic domains constitute PLP4 that has been linked to the 21.5 
kD isoform of human MBP (Fig. 2B).  
In SJL mice it has been shown that, when given under tolerogenic conditions, MP4 can 
prevent and revert EAE induced by MBP- and PLP-specific T cells (Elliot et al., 1996). It has 
also been shown that MP4 can induce EAE in SJL/J mice, and in another report (Jordan et 
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al., 1999) MP4 was found to be encephalitogenic in marmoset monkeys. Our studies later 
demonstrated that MP4 was also capable of inducing EAE in C57BL/6 mice, thus 
introducing a much needed alternative to the MOG:35-55 and PLP:178-191 peptide model 
(Kuerten et al., 2006). Overall, there are few systematic studies as to whether different EAE 
models can reproduce distinct features of MS histopathology. One typical problem is that – 
as mentioned above – the induction of EAE requires the specific combination of genetic 
strain and CNS antigen. Yet, it is difficult to compare results obtained in different models 
since it is unclear, which outcome can be ascribed to the antigen and which one depends on 
the genetic background (Kuerten et al., 2009). It is therefore crucial to modify only one 
variable at a time, that is either the antigen or the genetic background. With the introduction 
of the MP4 model on the C57BL/6 background, the spectrum of models on this background 
covered all main antigens known from MS pathology: MOG, MBP and PLP. In addition, this 
background offers the possibility of performing genetic modifications, facilitating 
mechanistic studies. 
In the following the characteristic histopathological features of MOG:35-55-, MP4- and 
PLP:178-191-induced EAE on the C57BL/6 background will be discussed and critically 
evaluated in the context of MS pathology considering the three hallmarks of MS pathology 
inflammation, demyelination and axonal damage.  
 
 
 
 
 
 
 
 
      A 
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Fig. 2. The molecular structure of the MBP-PLP fusion protein MP4. (A)  Structure of PLP. 
PLP is a transmembrane protein that consists of two extracellular (I and III) and an 
intracellular (II) hydrophilic domain, and four hydrophobic transmembrane sequences. (B)  
Structure of MP4. The three hydrophilic PLP domains have been fused to create PLP4, 
which has been linked to the 21.5 kD isoform of human MBP.  
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3. Studies on the CNS histopathology of EAE and its correlation with clinical 
and immunological parameters 
3.1 The CNS lesion topography and composition depends on the antigen used for 
immunization in models of C57BL/6 EAE 
Inflammation is a feature of MS pathology that can essentially be reproduced in any EAE 
model. In principle, pathology is initiated when autoreactive T cells enter the CNS. Before, 
these cells need to be primed in the secondary lymphoid organs. In MOG:35-55- and PLP:178-
191-induced EAE the antigen used for immunization is a single peptide and the autoreactive T 
cell response is directed against this peptide, while determinant spreading does not occur, 
which could include further determinants into the autoimmune response. The MP4 model, in 
contrast, is characterized by a multideterminant-specific CD4+ T cell response and we have 
shown that there is no single dominant determinant being recognized in mice immunized with 
MP4 (Kuerten et al., 2006). Rather, the response seems to randomly target different 
determinants of the MP4 protein with interindividual variation in individual mice. The 
advantage of multideterminant specificity in the MP4 model resides in the fact that it may be 
used to better mirror the heterogeneity of the T cell response present in MS patients. It has 
been shown that there is not a single determinant targeted by the autoimmune response in MS. 
Differences do not only exist between individual patients, but also develop as disease 
progresses, since new determinants can be engaged into the immune response through 
determinant spreading (Tuohy et al., 1998). In patients this is a random process, which is 
highly unpredictable and can at least in part account for the kinetics of disease progression.  
We assume that differences in the peripheral antigen-specific response have major 
implications on the subsequent CNS histopathology. In all models that we analyzed, 
infiltration of the cerebrum with focus on the meninges close to the hippocampal region 
occurred already in acute disease. In addition, in MP4- and PLP peptide-induced EAE 
inflammation of the spinal cord meninges was evident, while in the MOG peptide model 
inflammation extended into the parenchyma. Cerebellar infiltration was absent in the 
former two models, but pronounced in the latter in the acute stage of the disease. In chronic 
EAE (50 days after immunization), lesion distribution shifted towards the spinal cord and 
cerebellar parenchyma in the MP4 model, while it decreased remarkably in the cerebrum. In 
MOG peptide- and PLP peptide-induced EAE the lesion topography was comparable to the 
acute stage. Overall, CNS inflammation was time-dependent and dynamic only in the MP4 
model, shifting from the cerebrum to the spinal cord and finally involving the cerebellum, 
thus allows the staging of the disease (Kuerten et al., 2007). MS is characterized by lesion 
dissemination in time and space, for which the MP4 EAE could serve as a valuable model. In 
contrast, the PLP and MOG model showed rather static inflammatory patterns that 
remained unchanged throughout the disease.  
Next to differences in lesion topography we found differences in the cellular composition of 
CNS lesions. In particular, these differences pertained to the numbers of CNS infiltrating B 
cells.  
3.2 The development of tertiary lymphoid organs (TLOs) in MP4-induced EAE of 
C57BL/6 mice 
Studying the MP4, MOG peptide and PLP peptide model systematically early and late after 
immunization, we found that B cell infiltration was a common feature of the MP4 model, 
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